|
1
|
Wei WI and Sham JS: Nasopharyngeal
carcinoma. Lancet. 365:2041–2054. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Young LS and Rickinson AB: Epstein-Barr
virus: 40 years on. Nat Rev Cancer. 4:757–768. 2004.PubMed/NCBI
|
|
3
|
Spano JP, Busson P, Atlan D, Bourhis J,
Pignon JP, Esteban C and Armand JP: Nasopharyngeal carcinomas: an
update. Eur J Cancer. 39:2121–2135. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yu MC and Yuan JM: Epidemiology of
nasopharyngeal carcinoma. Semin Cancer Biol. 12:421–429. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Guigay J: Advances in nasopharyngeal
carcinoma. Curr Opin Oncol. 20:264–269. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lee AW, Yau TK, Wong DH, et al: Treatment
of stage IV(A–B) nasopharyngeal carcinoma by induction-concurrent
chemoradiotherapy and accelerated fractionation. Int J Radiat Oncol
Biol Phys. 63:1331–1338. 2005.
|
|
7
|
Le QT, Tate D, Koong A, et al: Improved
local control with stereotactic radiosurgical boost in patients
with nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys.
56:1046–1054. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lee AW, Sze WM, Au JS, et al: Treatment
results for nasopharyngeal carcinoma in the modern era: the Hong
Kong experience. Int J Radiat Oncol Biol Phys. 61:1107–1116. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sauane M, Gopalkrishnan RV, Sarkar D, et
al: MDA-7/IL-24: novel cancer growth suppressing and apoptosis
inducing cytokine. Cytokine Growth Factor Rev. 14:35–51. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Fisher PB: Is mda-7/IL-24 a ‘magic bullet’
for cancer? Cancer Res. 65:10128–10138. 2005.
|
|
11
|
Ramesh R, Mhashilkar AM, Tanaka F, et al:
Melanoma differentiation-associated gene 7/interleukin (IL)-24 is a
novel ligand that regulates angiogenesis via the IL-22 receptor.
Cancer Res. 63:5105–5113. 2003.PubMed/NCBI
|
|
12
|
Nishikawa T, Ramesh R, Munshi A, Chada S
and Meyn RE: Adenovirus-mediated mda-7 (IL24) gene therapy
suppresses angiogenesis and sensitizes NSCLC xenograft tumors to
radiation. Mol Ther. 9:818–828. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Caudell EG, Mumm JB, Poindexter N, et al:
The protein product of the tumor suppressor gene, melanoma
differentiation-associated gene 7, exhibits immunostimulatory
activity and is designated IL-24. J Immunol. 168:6041–6046. 2002.
View Article : Google Scholar
|
|
14
|
Ramesh R, Ito I, Gopalan B, Saito Y,
Mhashilkar AM and Chada S: Ectopic production of MDA-7/IL-24
inhibits invasion and migration of human lung cancer cells. Mol
Ther. 9:510–518. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Park MA, Yacoub A, Sarkar D, et al:
PERK-dependent regulation of MDA-7/IL-24-induced autophagy in
primary human glioma cells. Autophagy. 4:513–515. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yacoub A, Hamed HA, Allegood J, et al:
PERK-dependent regulation of ceramide synthase 6 and thioredoxin
play a key role in mda-7/IL-24-induced killing of primary human
glioblastoma multiforme cells. Cancer Res. 70:1120–1129. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hughes J, Alusi G and Wang Y: Gene therapy
and nasopharyngeal carcinoma. Rhinology. 50:115–121. 2012.
|
|
18
|
Li JH, Huang D, Sun BF, Zhang X,
Middeldorp J, Klamut H and Liu FF: Efficacy of ionizing radiation
combined with adenoviral p53 therapy in EBV-positive nasopharyngeal
carcinoma. Int J Cancer. 87:606–610. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Xie Y, Sheng W, Miao J, Xiang J and Yang
J: Enhanced antitumor activity by combining an adenovirus harboring
ING4 with cisplatin for hepatocarcinoma cells. Cancer Gene Ther.
18:176–188. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Su ZZ, Lebedeva IV, Sarkar D, et al:
Ionizing radiation enhances therapeutic activity of mda-7/IL-24:
overcoming radiation- and mda-7/IL-24-resistance in prostate cancer
cells overexpressing the antiapoptotic proteins bcl-xL or bcl-2.
Oncogene. 25:2339–2348. 2006. View Article : Google Scholar
|
|
21
|
Emdad L, Sarkar D, Lebedeva IV, et al:
Ionizing radiation enhances adenoviral vector expressing
mda-7/IL-24-mediated apoptosis in human ovarian cancer. J Cell
Physiol. 208:298–306. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Liu J, Sheng W, Xie Y, Shan Y, Miao J,
Xiang J and Yang J: The in vitro and in vivo antitumor activity of
adenovirus-mediated interleukin-24 expression for laryngocarcinoma.
Cancer Biother Radiopharm. 25:29–38. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wang X, Ye Z, Zhong J, Xiang J and Yang J:
Adenovirus-mediated Il-24 expression suppresses hepatocellular
carcinoma growth via induction of cell apoptosis and cycling arrest
and reduction of angiogenesis. Cancer Biother Radiopharm. 22:56–63.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Xie Y, Lv H, Sheng W, Miao J, Xiang J and
Yang J: Synergistic tumor suppression by adenovirus-mediated
inhibitor of growth 4 and interleukin-24 gene cotransfer in
hepatocarcinoma cells. Cancer Biother Radiopharm. 26:681–695. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
|
|
26
|
Schmittgen TD and Livak KJ: Analyzing
real-time PCR data by the comparative C(T) method. Nat Protoc.
3:1101–1108. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Madhusoodhanan R, Natarajan M,
Veeraraghavan J, Herman TS and Aravindan N: NFkappaB activity and
transcriptional responses in human breast adenocarcinoma cells
after single and fractionated irradiation. Cancer Biol Ther.
8:765–773. 2009. View Article : Google Scholar
|
|
28
|
Weidner N: Current pathologic methods for
measuring intratumoral microvessel density within breast carcinoma
and other solid tumors. Breast Cancer Res Treat. 36:169–180. 1995.
View Article : Google Scholar
|
|
29
|
Wang W, Qin SK, Chen BA and Chen HY:
Experimental study on antitumor effect of arsenic trioxide in
combination with cisplatin or doxorubicin on hepatocellular
carcinoma. World J Gastroenterol. 7:702–705. 2001.PubMed/NCBI
|
|
30
|
Li JH, Li P, Klamut H and Liu FF:
Cytotoxic effects of Ad5CMV-p53 expression in two human
nasopharyngeal carcinoma cell lines. Clin Cancer Res. 3:507–514.
1997.PubMed/NCBI
|
|
31
|
Pan JJ, Zhang SW, Chen CB, et al: Effect
of recombinant adenovirus-p53 combined with radiotherapy on
long-term prognosis of advanced nasopharyngeal carcinoma. J Clin
Oncol. 27:799–804. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Weinrib L, Li JH, Donovan J, Huang D and
Liu FF: Cisplatin chemotherapy plus adenoviral p53 gene therapy in
EBV-positive and -negative nasopharyngeal carcinoma. Cancer Gene
Ther. 8:352–360. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Harper JW, Adami GR, Wei N, Keyomarsi K
and Elledge SJ: The p21 Cdk-interacting protein Cip1 is a potent
inhibitor of G1 cyclin-dependent kinases. Cell. 75:805–816. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Toyoshima H and Hunter T: p27, a novel
inhibitor of G1 cyclin-Cdk protein kinase activity, is related to
p21. Cell. 78:67–74. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Danial NN and Korsmeyer SJ: Cell death:
critical control points. Cell. 116:205–219. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Dvorak HF: Vascular permeability
factor/vascular endothelial growth factor: a critical cytokine in
tumor angiogenesis and a potential target for diagnosis and
therapy. J Clin Oncol. 20:4368–4380. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Moeller BJ, Cao Y, Li CY and Dewhirst MW:
Radiation activates HIF-1 to regulate vascular radiosensitivity in
tumors: role of reoxygenation, free radicals, and stress granules.
Cancer Cell. 5:429–441. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Camphausen K, Moses MA, Beecken WD, Khan
MK, Folkman J and O’Reilly MS: Radiation therapy to a primary tumor
accelerates metastatic growth in mice. Cancer Res. 61:2207–2211.
2001.PubMed/NCBI
|
